Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Salix alba bark volatile oil is a natural plant extract derived from the bark of the white willow tree (*Salix alba*). It is primarily utilized as an ingredient in over-the-counter (OTC) topical formulations and dietary supplements. While the bark of *Salix alba* is historically recognized as the natural source of salicin—a compound that served as the blueprint for aspirin—the volatile oil fraction contains a complex mixture of aromatic compounds, including salicylates and terpenes, which are thought to provide anti-inflammatory and analgesic properties. Unlike standardized pharmaceutical willow bark extracts, the volatile oil is not typically developed as a regulated drug for specific clinical indications but is instead found in traditional medicine and wellness products for the relief of minor aches and pains.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on salix alba bark volatile oil.